Please login to the form below

Not currently logged in


This page shows the latest lampalizumab news and features for those working in and with pharma, biotech and healthcare.

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway

Lampalizumab in phase III for age-related maculardegeneration.  . Roche has started enrolling patients into phase III trials of lampalizumab for dry age-related macular degeneration (AMD) - a major cause of blindness. ... With the phase III trials for

Latest news

  • Roche moves eye drug lampalizumab into phase III Roche moves eye drug lampalizumab into phase III

    Sandra Horning, head of global product development and chief medical officer at Roche, said: “Lampalizumab has the potential to represent a significant breakthrough for this disease and could provide real hope ... To date lampalizumab showed a 20%

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...